AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

1

The AMA and Vaccine Integrity Project launched an initiative to assess vaccine safety and effectiveness for the 2026-2027 season.
2

This initiative aims to create a formal process for evaluating scientific evidence supporting respiratory virus vaccinations.
3

The review process will include expert panels, systematic literature reviews, and public protocols for data transparency.
4

The AMA's involvement marks a shift towards prioritizing public health evidence in vaccine recommendations.
5

The initiative seeks to restore confidence in vaccines through continuous evaluation and credible evidence for clinicians.

1